Resolution Medical, a part of Arcline Investment Management and a leading medical device contract development and manufacturing firm, has announced the acquisition of LifeTec GroupTM. LifeTec is a Dutch firm and a premier pre-clinical contract research organization (CRO) globally.
"LifeTec's biosimulation services and technologies add clinical insight depth and accelerate R&D execution for medical device companies around the world. We have long been impressed by the LifeTec team's capabilities, and are extremely excited to come together. Our customers look for fully integrated development and manufacturing capabilities, fast and agile execution, and clinically deep anatomical and physiological expertise. That is what Resolution Medical offers and embodies. LifeTec is a fantastic addition to further our mission of Partnering to Bring the Frontiers of Medical Technology to Life."
Luke Johnson, CEO of Resolution Medical
“Medical technology innovation is best achieved by integrating design, prototyping, pre-clinical verification and validation, and manufacturing. We've found an excellent partner in Resolution Medical to globally leverage the value we bring by combining our unparalleled pre-clinical services with their best-in-class development and manufacturing services. We're incredibly excited to join Resolution Medical and shape the future of accelerated medical technology innovation."
Jurgen de Hart, CEO of LifeTec
Johnson further commented, "Resolution Medical has just finished a new 35,000 sq. ft. dedicated R&D facility in Minneapolis, adjacent to our current facility, which will be fully dedicated to manufacturing. Within that new R&D facility we now have a state-of-the-art biosimulation lab that leverages LifeTec's multiple simulation platforms and many years of expertise. This lab includes ultrasound and fluoroscopy imaging, and we are excited to now begin offering this service to our customers at sites both in the U.S. and Europe."